Smith & Nephew plc  

(Public, LON:SN)   Watch this stock  
Find more results for SN
1,188.70
+2.70 (0.23%)
Feb 27 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 858.50 - 1,211.00
Open     -
Vol / Avg. 0.00/2.28M
Mkt cap 10.62B*
P/E 32.80
Div/yield 12.14/1.65*
EPS 0.36*
Shares 895.58M
Beta     -
Inst. own     -
*GBP
Apr 30, 2015
Q1 2015 Smith & Nephew PLC Earnings Release - 8:00AM GMT+1 - Add to calendar
Apr 9, 2015
Smith & Nephew PLC Annual Shareholders Meeting Add to calendar
Mar 25, 2015
Smith & Nephew PLC Analyst & Investor Meetings - 2:30PM GMT - Add to calendar
Feb 5, 2015
Q4 2014 Smith & Nephew PLC Earnings Call - Webcast
Feb 5, 2015
Q4 2014 Smith & Nephew Earnings Release
Jan 12, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Jan 12, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Dec 4, 2014
Smith & Nephew PLC at Berenberg European Conference
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 12.81% 10.85%
Operating margin 17.93% 16.07%
EBITD margin - 29.56%
Return on average assets 8.58% 7.63%
Return on average equity 15.93% 12.39%
Employees 14,000 -
CDP Score - 95 B

Address

15 Adam Street
LONDON, WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices consisting orthopaedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company�s Advanced Surgical Devices (ASD) segment offers products and technologies include orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other ASD. The Company�s Advanced Wound Management (AWM) segment offers products include Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 90 countries.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 55
Julie Brown Chief Financial Officer, Executive Director
Age: 51
Rodrigo Bianchi President, IRAMEA
Age: 54
Michael G. Frazzette President - Advanced Surgical Devices
Age: 52
R. Gordon Howe President - Global Operations
Age: 51
Roger Teasdale President - Advanced Wound Management
Age: 46
Francisco Canal Vega President - Latin America
Age: 52
John W. Campo Chief Legal Officer
Age: 59
Helen Maye Chief Human Resources Officer
Age: 54
Cyrille Petit Chief Corporate Development Officer
Age: 43